Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Decibel Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q4 2022
- Shares held
- 15.5M
- −2.03M (−11.6%) vs. Q4 2022
- Total value
- $46.7M
- +$10.8M (+30.2%) vs. Q4 2022
- New holders
- 3
- 10 more added
- Sold out
- 4
- 11 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 204 | $0 | 0.00% | −507−71.3% | Reduced |
| Financial Connections Group, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 46 | $139 | 0.00% | +46 | New |
| Wells Fargo & Company | 90 | $272 | 0.00% | +2+2.3% | Added |
| Cubist Systematic Strategies, LLC | 571 | $1.72K | 0.00% | −231−28.8% | Reduced |
| Bank of America Corp | 750 | $2.27K | 0.00% | −40−5.1% | Reduced |
| Royal Bank of Canada | 1,038 | $3.00K | 0.00% | +816+367.6% | Added |
| Tower Research Capital LLC (TRC) | 5,093 | $15.0K | 0.00% | −4,885−49.0% | Reduced |
| Flagship Harbor Advisors, LLC | 10,113 | $30.5K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 10,855 | $32.8K | 0.00% | −227,822−95.5% | Reduced |
| Laurion Capital Management LP | 11,990 | $36.2K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 14,900 | $45.0K | 0.00% | +14,900 | New |
| Neuberger Berman Group LLC | 15,661 | $47.3K | 0.00% | −600−3.7% | Reduced |
| Morgan Stanley | 16,126 | $48.7K | 0.00% | +5,566+52.7% | Added |
| Northern Trust Corp | 19,091 | $57.7K | 0.00% | +2,048+12.0% | Added |
| Marquette Asset Management, LLC | 19,783 | $59.7K | 0.02% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 20,000 | $60.4K | 0.00% | 00.0% | Unchanged |
| Atlas Capital Advisors LLC | 25,000 | $75.5K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 32,500 | $98.0K | 0.00% | −3,894−10.7% | Reduced |
| Dimensional Fund Advisors LP | 34,607 | $104.5K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 40,489 | $122.3K | 0.00% | +12,757+46.0% | Added |
| State Street Corp | 40,960 | $123.7K | 0.00% | +5,800+16.5% | Added |
| Geode Capital Management, LLC | 115,567 | $349.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 119,100 | $359.7K | 0.01% | +7,118+6.4% | Added |
| JPMorgan Chase & Co | 125,661 | $379.0K | 0.00% | −4,911−3.8% | Reduced |
| Point72 Asset Management, L.P. | 132,000 | $398.6K | 0.00% | +42,000+46.7% | Added |
| Bronte Capital Management Pty Ltd. | 157,455 | $475.5K | 0.06% | −1,950−1.2% | Reduced |
| UBS Oconnor LLC | 189,386 | $571.9K | 0.01% | +189,386 | New |
| Millennium Management LLC | 246,317 | $744.0K | 0.00% | −242,466−49.6% | Reduced |
| Newtyn Management, LLC | 253,818 | $766.5K | 0.15% | −16,182−6.0% | Reduced |
| Harvard Management Co Inc | 328,798 | $993.0K | 0.10% | 00.0% | Unchanged |
| Bessemer Group Inc | 494,071 | $1.49M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 642,325 | $1.94M | 0.00% | +15,021+2.4% | Added |
| Samsara BioCapital, LLC | 801,629 | $2.42M | 0.50% | 00.0% | Unchanged |
| Alphabet Inc. | 1,636,258 | $4.94M | 0.27% | 00.0% | Unchanged |
| BlackRock Inc. | 1,806,146 | $5.45M | 0.00% | +1,038+0.1% | Added |
| TRV GP III, LLC | 3,139,685 | $9.48M | 11.43% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $14.9M | 0.30% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,787,311−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −23,480−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,345−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |